UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2022~~2023

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________to_________

Commission file number 333-198772

~~Alpha Investment Inc.~~(Exact name of registrant as specified in its charter)

(Former Name of Registrant as Specified in its Charter)

Delaware		90-0998139
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

200 East Campus View Blvd., Suite 200

Columbus, OH 43235

(Address of principal executive offices) (zip code)

305-704-3294

(Registrant's telephone number, including area code)

The Registrant does not have any securities registered pursuant to Section 12(b) of the Exchange Act.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

x Yes o No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.)

x Yes o No

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
None

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated filer o Accelerated filer o Non-accelerated filer ox Smaller reporting company x Emerging growth Company o

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

o Yes x No

Indicate the number of shares outstanding of each of the registrant's classes of common stock as of the latest practicable date.

Class		Outstanding at ~~December~~July 1615, ~~2022~~2023
Common Stock, par value $0.0001		911,~~724~~224,401 shares

Documents incorporated by reference: None

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION

	Page No.
Item 1. Financial Statements.
Condensed Consolidated Balance Sheets as of September 30, 2022 (unaudited) and December 31, 2021	5
Condensed Consolidated Balance Sheets as of March 31, 2023 (unaudited) and December 31, 2022	5
Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2022 and 2021 (unaudited)	6
Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2023 and 2022 (unaudited)	6
Condensed Consolidated Statement of Changes in Stockholders’ Equity for the Three and Nine Months Ended September 30, 2022 and 2021 (unaudited)	7
Condensed Consolidated Statement of Changes in Stockholders’ Equity for the Three Months Ended March 31, 2023 and 2022 (unaudited)	7
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2022 and 2021 (unaudited)	8
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2023 and 2022 (unaudited)	8
Notes to Unaudited Condensed Consolidated Financial Statements	9 – 1615
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.	1716 – 1817
Item 3. Quantitative and Qualitative Disclosures About Market Risk.	1817
Item 4. Controls and Procedures.	1917 – 18

PART II - OTHER INFORMATION

Item 1. Legal Proceedings. 2018 Item 1A. Risk Factors. 2019 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 2019 Item 3. Defaults Upon Senior Securities. 2019 Item 4. Mine Safety Disclosures. 2019 Item 5. Other Information. 2019 Item 6. Exhibits. 2019

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This report includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Words such as, but not limited to, “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “targets,” “likely,” “aim,” “will,” “would,” “could,” and similar expressions or phrases identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and future events and financial trends that we believe may affect our financial condition, results of operation, business strategy and financial needs. Forward-looking statements include, but are not limited to, statements about:

Ÿ· our lack of significant revenues and history of losses,

Ÿ· our ability to continue as a going concern,

Ÿ· our ability to raise additional working capital as necessary,

Ÿ· our ability to satisfy our obligations as they become due,

Ÿ· the failure to successfully commercialize our product or sustain market acceptance,

Ÿ· the reliance on third party agreements and relationships for development of our business,

Ÿ· the control exercised by our management,

Ÿ· the impact of government regulation on our business,

Ÿ· our ability to effectively compete,

Ÿ· the possible inability to effectively protect our intellectual property,

Ÿ· the lack of a public market for our securities and the impact of the penny stock rules on trading in our common stock should a public market ever be established.

You should read thoroughly this report and the documents that we refer to herein with the understanding that our actual future results may be materially different from and/or worse than what we expect. We qualify all of our forward-looking statements by these cautionary statements including those made in this report, in Part I. Item 1A. Risk Factors appearing in our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 and our other filings with the Securities and Exchange Commission. Other sections of this report include additional factors which could adversely impact our business and financial performance. New risk factors emerge from time to time and it is not possible for our management to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Except for our ongoing obligations to disclose material information under the Federal securities laws, we undertake no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events. These forward-looking statements speak only as of the date of this report, and you should not rely on these statements without also considering the risks and uncertainties associated with these statements and our business.

OTHER PERTINENT INFORMATION

Unless specifically set forth to the contrary, when used in this report the terms “the “Company,” “we,” “our,” “us,” and similar terms refers to Alpha Investment, Inc.

ITEM 1. FINANCIAL STATEMENTS

Alpha Investment Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

	As of			As of
	September 30,			December 31,
	March 31,			December 31,
	2022			2021
	2023			2022
ASSETS
Current Assets:
Cash	$	~~127~~—		$	~~588~~—
Total Current Assets		~~127~~—			~~588~~—
Other Assets:
Loans receivable - related party, net of discounts		—			—
Loans receivable, net of discounts		—			—
Interest receivable		—			—
Total Other Assets		—			—
Property and Equipment, net:
Furniture and Equipment, net		79—			~~316~~—
Total Property and Equipment, net		79			316
Total Property, Plant and Equipment		—			—
TOTAL ASSETS	$	~~206~~—		$	~~904~~—
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts payable	$	~~506~~651,~~691~~866		$	~~310~~602,~~726~~416
Accrued management fees - related party		~~412~~487,500			~~300~~450,000
Distribution payable		~~430~~490,000			~~340~~460,000
Notes payable - short-term		3742,~~100~~954			—39,279
Notes payable - related party		~~225~~238,~~185~~309			~~205~~231,~~497~~747
Judgments payable		2,518,000			—
Judgments and settlements payable		2,662,147			2,518,000
Total Current Liabilities		4,~~129~~572,~~476~~776			14,~~156~~301,~~223~~442
Payroll Protection Plan Loan		—			—
Total Liabilities		4,572,776			4,301,442
Total Liabilities		4,129,476			1,156,223
Temporary Equity:
Series 2018 Convertible Preferred Stock ($0.0001 par value), net of discounts of $134,247 and $140,169, respectively, 100,000 shares authorized; 36,667 shares issued and outstanding (liquidation value: $500,000) (See Note 7)		428,176			410,410
Series 2018 Convertible Preferred Stock ($0.0001 par value), net of discounts of $110,559 and $116,481, respectively, 100,000 shares authorized; 36,667 shares issued and outstanding (liquidation value: $500,000) (See Note 8)		440,020			434,098
		428,176			410,410
		440,020			434,098
Stockholders' Equity:
Preferred stock ($0.0001 par value), 20,000,000 shares
Series A Convertible Preferred stock ($15.00 par value), 100,000 shares authorized; 1,167 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively		17,505			17,505
Series A Convertible Preferred stock ($15.00 par value), 100,000 shares authorized; 1,167 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively		17,505			17,505
Series AA Convertible Preferred stock ($0.0001 par value), 100,000 shares authorized, 100,000 and -0- issued and outstanding as of September 30, 2022 and December 31, 2021, respectively		10			10
Series AA Convertible Preferred stock ($0.0001 par value), 100,000 shares authorized, 100,000 and 100,000 issued and outstanding as of March 31, 2023 and December 31, 2022, respectively		10			10
Common stock, ($0.0001 par value), 100,000,000 shares authorized; 9,724,401 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively		973			973
Common stock, ($0.0001 par value), 100,000,000 shares authorized; 9,724,401 and 9,724,401 shares issued and outstanding as of March 31, 2023 and December 31, 2021, respectively		973			973
Additional paid-in capital		6,~~012~~021,~~900~~150			56,~~939~~012,~~250~~900
Accumulated deficit		(10,~~250~~653,~~322~~922	)		(710,~~274~~398,~~955~~416	)
Total Equity		(4,~~218~~614,~~934~~284	)		(14,~~317~~367,~~217~~028	)
Non-controlling interest in variable interest entities		(~~338~~398,512	)		(~~248~~368,512	)
Total Stockholders' Equity		(45,~~557~~012,~~446~~796	)		(14,~~565~~735,~~729~~540	)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	~~206~~—		$	~~904~~—

Series A Convertible Preferred Stock

See notes to unaudited condensed consolidated financial statements.

ALPHA INVESTMENT INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months			Three Months			~~Nine Months~~			~~Nine Months~~
	Ended			Ended			~~Ended~~			~~Ended~~
	September 30,			September 30,			September 30,			September 30,
	March 31,			March 31,
	2022			2021			2022			2021
	2023			2022
Income:
Net investment income - related parties	$	—		$	~~7,193~~—		$	—		$	~~21,579~~
Net investment income		—			—			—			—
Total Income		—			~~7,193~~—			—			~~21,579~~
General and Administrative Expenses:
Management fee - related party		37,500			37,500			~~112,500~~			~~112,500~~
Administrative expenses		6325,~~556~~023			1361,~~015~~867			~~186,222~~			~~72,068~~
Professional fees		1532,~~660~~677			4220,~~367~~432			~~119,092~~			~~104,350~~
Total General and Administrative Expenses		~~116~~95,~~716~~200			92119,~~882~~799			~~417,814~~			~~288,917~~
Loss from Operations		(~~116~~95,~~716~~200	)		(85119,~~688~~799	)		~~(417,814~~	)		~~(267,338~~	)
Other Expense:
Other income/expense								(2,518,000	)		20,927
Judgment payable		(144,147	)		—
Interest expense, net		(810,~~662~~238	)		(26,~~917~~562	)		~~(21,787~~	)		~~(13,126~~	)
Total Other Expense		(8154,~~662~~385	)		(26,~~917~~562	)		~~(2,539,787~~	)		~~7,801~~
Net Loss	$	(~~125~~249,~~378~~584	)	$	(88126,~~605~~361	)	$	~~(2,957,601~~	)	$	~~(259,537~~	)
Amortization of discounts on Series 2018 preferred stock and redeemable common stock		(5,922	)		(5,922	)		~~(17,766~~	)		~~(17,766~~	)
Net Income Attributable to Non-controlling Interests		—			(8,967	)		—			(26,900	)
Net Loss Attributable to Common Stockholders	$	(255,506	)	$	(132,283	)
Net Loss Attributable to Common Stockholders	$	(131,300	)	$	(103,494	)	$	(2,975,367	)	$	(304,203	)
Basic and Diluted Loss Per Share	$	(0.03	)	$	(0.01	)
Basic and Diluted Loss Per Share	$	(0.01	)	$	(0.01	)	$	(0.31	)	$	(0.02	)
Basic and Diluted Weighted Average Number of Common Shares Outstanding		9,724,401			9,724,401
Basic and Diluted Weighted Average Number of Common Shares Outstanding		9,724,401			9,724,401			9,724,401			14,632,190

See notes to unaudited condensed consolidated financial statements.

Alpha Investment Inc.

~~Condensed Consolidated~~ Statement of Changes in Stockholders' Equity (Deficit)

~~(Unaudited)~~For the Three Months Ended March 31, 2022 and 2021

								~~Series A~~		Series A			~~Series AA~~			Series AA					~~Non-~~				Non-
	~~Common Stock~~	Common Stock						~~Preferred Stock~~		Preferred Stock			~~Preferred Stock~~			Preferred Stock		~~Paid-in~~			~~controlling~~	Paid-in		~~Accumulated~~	controlling				Accumulated
	~~Shares~~	Shares		~~Amount~~		Amount		~~Shares~~		Shares	~~Amount~~		~~Shares~~Amount		~~Amount~~	Shares		~~Capital~~	Amount		~~Interest~~	Capital		~~Deficit~~	Interest			~~Total~~	Deficit			Total
Balance, December 31, 2020		40,290,400		$	4,030				1,167		$	17,505		—	$	—		$	5,547,717		$	(164,380	)	$	(5,150,676	)		$	254,196
Balance, December 31, 2021			9,724,401			$	973				1,167		$	17,505			100,000		$	10		$	5,939,250		$	(248,512	)		$	(7,274,955	)	$	(1,565,729	)
Stock exchange		~~(30,565,999~~	)		~~(3,057~~	)	—		—		—	—		~~100,000~~—		10	—		~~3,047~~	—		—	—		—	—			—	—			—
Stockholder contribution		—	—		—		—		—		—	—		—		—	—		~~81,650~~	—		—	32,600		—	—			~~81,650~~	—			32,600
Distributions due to non-controlling interest		—	—		—		—		—		—	—		—		—	—		—	—		~~(30,000~~	)—		—	(30,000	)		~~(30,000~~	)—			(30,000	)
Amortization of discount on redeemable preferred stock		—	—		—		—		—		—	—		—					—			—	—		~~(5,922~~	)—			~~(5,922~~	)(5,922	)		(5,922	)
Net loss		—	—		—		—		—		—	—		—		—	—		—	—		~~8,967~~	—		~~(110,609~~	)			~~(101,642~~	)(126,361	)		(126,361	)
Balance, March 31, 2021		9,724,401		$	973				1,167		$	17,505		100,000	$	10		$	5,632,414		$	(185,413	)	$	(5,267,207	)		$	198,282
Balance, March 31, 2022			9,724,401			$	973				1,167		$	17,505			100,000		$	10		$	5,971,850		$	(278,512	)		$	(7,407,238	)	$	(1,695,412	)
Stockholder contribution		—			—				—			—		—		—			56,061			—			—				56,061
Distributions due to non-controlling interest		—			—				—			—		—		—			—			(30,000	)		—				(30,000	)
Amortization of discount on redeemable preferred stock		—			—				—			—							—			—			(5,922	)			(5,922	)
Net loss		—			—				—			—		—		—			—			8,967			(78,257	)			(69,290	)
Balance, June 30, 2021		9,724,401		$	973				1,167		$	17,505		100,000	$	10		$	5,688,475		$	(206,447	)	$	(5,351,386	)		$	149,131
Stockholder contribution		—			—				—			—		—		—			53,500			—			—				53,500
Distributions due to non-controlling interest		—			—				—			—		—		—			—			(30,000	)		—				(30,000	)
Amortization of discount on redeemable preferred stock		—			—				—			—							—			—			(5,922	)			(5,922	)
Net loss		—			—				—			—		—		—			—			8,967			(97,572	)			(88,605	)
Balance, September 30, 2021		9,724,401		$	973				1,167		$	17,505		100,000	$	10		$	5,741,975		$	(227,480	)	$	(5,454,879	)		$	78,104

								~~Series A~~		Series A			~~Series AA~~			Series AA					~~Non-~~				Non-
	~~Common Stock~~	Common Stock						~~Preferred Stock~~		Preferred Stock			~~Preferred Stock~~			Preferred Stock		~~Paid-in~~			~~controlling~~	Paid-in		~~Accumulated~~	controlling				Accumulated
	~~Shares~~	Shares		~~Amount~~		Amount		~~Shares~~		Shares	~~Amount~~		~~Shares~~Amount		~~Amount~~	Shares		~~Capital~~	Amount		~~Interest~~	Capital		~~Deficit~~	Interest			~~Total~~	Deficit			Total
Balance, December 31, 2021		9,724,401		$	973				1,167		$	17,505		100,000	$	10		$	5,939,250		$	(248,512	)	$	(7,274,955	)		$	(1,565,729	)
Balance, December 31, 2022			9,724,401			$	973				1,167		$	17,505			100,000		$	10		$	6,012,900		$	(368,512	)		$	(10,398,416	)	$	(4,735,540	)
Stockholder contribution		—	—		—		—		—		—	—		—		—	—		~~32,600~~	—		—	8,250		—	—			~~32,600~~	—			8,250
Distributions due to non-controlling interest		—	—		—		—		—		—	—		—		—	—		—	—		~~(30,000~~	)—		—	(30,000	)		~~(30,000~~	)—			(30,000	)
Amortization of discount on redeemable preferred stock		—	—		—		—		—		—	—		—		—	—		—	—		—	—		~~(5,922~~	)—			~~(5,922~~	)(5,922	)		(5,922	)
Net loss		—	—		—		—		—		—	—		—		—	—		—	—			—		~~(126,361~~	)			~~(126,361~~	)(249,584	)		(249,584	)
Balance, March 31, 2022		9,724,401		$	973				1,167		$	17,505		100,000	$	10		$	5,971,850		$	(278,512	)	$	(7,407,238	)		$	(1,695,412	)
Balance, March 31, 2023			9,724,401			$	973				1,167		$	17,505			100,000		$	10		$	6,021,150		$	(398,512	)		$	(10,653,922	)	$	(5,012,796	)
Stockholder contribution		—			—				—			—		—		—			41,050			—			—				41,050
Distributions due to non-controlling interest		—			—				—			—		—		—			—			(30,000	)		—				(30,000	)
Amortization of discount on redeemable preferred stock		—			—				—			—		—		—			—			—			(5,922	)			(5,922	)
Net loss		—			—				—			—		—		—			—						(2,705,862	)			(2,705,862	)
Balance, June 30, 2022		9,724,401		$	973				1,167		$	17,505		100,000	$	10		$	6,012,900		$	(308,512	)	$	(10,119,022	)		$	(4,396,146	)
Stockholder contribution		—			—				—			—		—		—			—			—			—				—
Distributions due to non-controlling interest		—			—				—			—		—		—			—			(30,000	)		—				(30,000	)
Amortization of discount on redeemable preferred stock		—			—				—			—		—		—			—			—			(5,922	)			(5,922	)
Net loss		—			—				—			—		—		—			—						(125,378	)			(125,378	)
Balance, September 30, 2022		9,724,401		$	973				1,167		$	17,505		100,000	$	10		$	6,012,900		$	(338,512	)	$	(10,250,322	)		$	(4,557,446	)

Common Stock

Series A Preferred Stock

Series AA Preferred Stock

Paid-In Capital

Non-Controlling Interest

Accumulated Deficit

See notes to unaudited condensed consolidated financial statements.

ALPHA INVESTMENT INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months			Nine Months
	Three Months			Three Months
	Ended			Ended
	September 30,			September 30,
	March 31,			March 31,
	2022			2021
	2023			2022
Cash Flows from Operating Activities:
Net loss	$	(2249,~~957,601~~584	)	$	(~~259~~126,~~537~~361	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation Expense		~~237~~—			~~237~~79
Accretion of origination fee income		—			~~(6,870~~—	)
Amortization of deferred loan costs		—			~~35,430~~—
Payroll protection loan forgiveness		—			(20,927	)
Changes in operating assets and liabilities:
Increase in judgments payable		1,518,000
Increase in interest receivable		—			—
Increase in settlements payable		1,000,000
Increase in accrued management fees - related party		37,500			37,500
Increase in interest receivable		—			(50,139	)
Decrease in accounts payable and accrued expenses		49,450			49,033
Increase in accrued management fees - related party		112,500			112,500
Increase in notes payable - short term		3,675
Decrease in accounts payable and accrued expenses		195,965			(19,909	)
Increase in notes payable - related party		6,562			6,561
Increase in interest payable		2,100
Increase in judgments & settlements payable		144,147			—
Increase in notes payable - related party		19,688			13,125
Net cash used in operating activities		(8,250	)		(33,188	)
Net cash used in operating activities		(109,111	)		(196,090	)
Cash Flows from Investing Activities:
Net cash from investing activities		—			—
Cash Flows from Financing Activities:
Proceeds from short term loan		35,000			—
Proceeds from stockholder contribution		8,250			32,600
Proceeds from stockholder contribution		73,650			191,211
Net cash provided by (used in) financing activities		8,250			32,600
Net cash provided by (used in) financing activities		108,650			191,211
Net increase (decrease) in cash		—			(588	)
Net increase (decrease) in cash		(461	)		(4,879	)
Cash and restricted cash at beginning of quarter		—			588
Cash and restricted cash at beginning of year		588			11,624
Cash and restricted cash at end of year		—		$	—
Cash and restricted cash at end of year	$	127		$	6,745
Supplemental Disclosure of Cash Flow Information:
Cash paid during year for:
Interest	$	—		$	—
Income Taxes	$	—		$	—
Schedule of Non-Cash Investing and Financing Activities:
Distribution due to non-controlling interest	$	9030,000		$	9030,000
Amortization of discount on redeemable preferred stock	$	175,~~766~~922		$	175,~~766~~922

See notes to unaudited condensed consolidated financial statements.

ALPHA INVESTMENT INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

Alpha Investment Inc, formerly GoGo Baby, Inc. (the “Company”) was incorporated on February 22, 2013 under the laws of the State of Delaware to develop, create, manufacture and market, toys for small children which would be designed to attach to car seats and amuse and entertain children during a drive, without distracting the attention of the driver. The Company, however, encountered significant constraints in raising sufficient capital to fully implement its business plan.

To better reflecting management’s shifted focus of the Company’s business to real estate and other commercial lending, on March 30, 2017, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Delaware Secretary of State changing its name from “Gogo Baby, Inc.” to “Alpha Investment Inc.”. The name change and a corresponding change in the Company’s OTC markets trading symbol from GGBY to ALPC received approval from FINRA and became effective as of April 19, 2017.

On March 11, 2019, the Company, through Alpha Mortgage Notes I, LLC (the “SPV”) entered into an operating agreement with Alameda Partners LLC, a Utah limited liability company (“Alameda Partners”). Alameda Partners acquired a ten percent (10%) equity interest in the SPV in exchange for a payment of $1,000,000 to the Company and is the managing member of the SPV. The capital is intended for use in implementing the Company’s strategy of acquiring commercial real estate performing notes and support other related growth initiatives and assets acquisitions for the Company The principals of Alameda Partners have significant long-term of experience in the commercial real estate industry as property developers, owners, and managers and currently hold over $50 million in commercial real estate assets. Pursuant to the operating agreement for the SPV, Alameda Partners is entitled to monthly distributions in cash or stock equal to $10,000. As of ~~September~~March 3031, ~~2022~~2023, the SPV has not completed any transactions. On July 30, 2020, Alpha entered a joint venture transaction with Parsons Energy Group, LLC (“Parsons”) with respect to leasehold mining rights then held by Parsons on approximately 1,200 acres located in Independence, Wisconsin.

On July 2130, ~~2021~~2020, ~~the~~Alpha ~~Company and Parsons~~ entered ~~into~~ ana ~~Unwinding Agreement (the “Unwinding Agreement“), pursuant to which the~~ joint venture ~~was unwound. Under the Unwinding~~transaction ~~Agreement,~~with Parsons ~~returned~~Energy ~~the~~Group, ~~Series~~LLC ~~2020~~(“Parsons”) ~~Preferred~~with ~~Shares~~respect to ~~the~~leasehold ~~Company~~mining ~~for~~rights ~~cancellation~~then ~~and~~held ~~the~~by ~~Company~~Parsons ~~assigned~~on ~~the Interest in~~approximately ~~Legacy~~1,200 ~~Sand~~acres ~~back~~located toin ~~Parsons~~Independence, ~~and exchanged mutual releases~~Wisconsin.

On July 21, 2021, the Company and Parsons entered into an Unwinding Agreement (the “Unwinding Agreement”), pursuant to which the joint venture was unwound. Under the Unwinding Agreement, Parsons returned the Series 2020 Preferred Shares to the Company for cancellation and the Company assigned the Interest in Legacy Sand back to Parsons and exchanged mutual releases.

NOTE 2 – GOING CONCERN

Future issuances of the Company’s equity or debt securities will be required for the Company to continue to finance its operations and continue as a going concern. The Company’s present revenues are insufficient to meet operating expenses. The financial statements of the Company have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has an accumulated deficit of $10,~~250~~653,~~322~~922 as of ~~September~~March 3031, ~~2022~~2023. During the ~~nine~~ three months ended ~~September~~March 3031, ~~2022~~2023, the Company used $~~109~~8,~~111~~250 of cash in operations and incurred a net loss of $2249,~~957,601~~584. The Company requires capital for its contemplated operational and marketing activities to take place. The Company's ability to raise additional capital through the future issuances of common stock is unknown. Securing additional financing, the successful development of the Company's contemplated ~~plan~~ plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raise substantial doubt about the Company's ability to continue as a going concern. The financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which we considered as necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2021. The results of operations for the nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for future periods or the full year.

Company's Annual Report on Form 10-K for the year ended December 31, 2022. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for future periods or the full year.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company, Alpha Mortgage Notes I, LLC, which is controlled by the Company through its 90% ownership interest, and Paris Med CP-LLC (“Paris Med”), a variable interest entity for which the Company is deemed to be the primary beneficiary, (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods presented. The Company is required to make judgments and estimates about the effect of matters that are inherently uncertain. The Company regularly evaluates estimates and assumptions related to the useful life and recoverability of long-lived assets, deferred income tax asset valuations and loss contingences. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Although, we believe our judgments and estimates are appropriate, actual future results may be different; if different assumptions or conditions were to prevail, the results could be materially different from our reported results.

Cash and Cash Equivalents

Cash equivalents include short-term, highly liquid investments with maturities of three months or less at the time of acquisition. As of ~~September~~March 3031, ~~2022~~2023, the Company ~~has~~had ~~$127 in cash and~~ no cash equivalents.

Loans Receivable, net and Allowance for Losses

The Company records its investments in loans receivable at the lower of cost or fair value. Costs are the gross loan receivables less unamortized costs of issuance and deferred origination fees. Origination fees collected at the time of investment are recorded against the loans receivable and amortized into net interest income over the lives of the related loans. Issuance costs incurred are capitalized along with the initial investment and amortized against net interest income over the lives of the related loans.

When a loan receivable is placed on non-accrual status, the related interest receivable is charged to bad debt of the current period. If a non-accrual loan is returned to accrual status, the accrued interest existing at the date the residential loan is placed on non-accrual status and interest during the non-accrual period are recorded as interest income as of the date the loan no longer meets the non-accrual criteria.

The Company maintains an allowance for loan losses on its investments in real estate loans receivable for estimated credit impairment. Management’s estimate of losses is based on several factors including the types and dollar amounts of loans in the portfolio, adverse situations that may affect the borrower’s ability to repay, prevailing economic conditions and the underlying collateral securing the loan. Additions to the allowance are provided through a charge to earnings and are based on an assessment of certain factors, which may indicate estimated losses on the loans. Actual losses on loans are recorded first as a reduction to the allowance for loan losses. Generally, subsequent recoveries of amounts previously charged off are recognized as income.

Estimating allowances for loan losses requires significant judgment about the underlying collateral, including liquidation value, condition of the collateral, competency and cooperation of the related borrower and specific legal issues that affect loan collections or taking possession of the property on an individual loan receivable basis. Management has established an allowance of $1,633,380 as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022.

Property and Equipment

Property and equipment are stated at cost. Equipment and fixtures will be depreciated using the straight-line method over the estimated asset lives, 5 years. As at September 30, 2022 and December 31, 2021, the Company recorded $79 and $316 in property and equipment, net of $1,798 and $1,561 in accumulated depreciation, and recorded $237 in depreciation expense at September 30, 2022 and 2021.

Mortgage Receivables

Equipment and Fixtures

Income Taxes

The Company accounts for its income taxes in accordance with FASB Accounting Standards Codification (“ASC”) No. 740, "Income Taxes". Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax balances. Deferred tax assets and liabilities are measured using enacted or substantially enacted tax rates expected to apply to the taxable income in the years in which those differences are expected to be recovered or settled. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment or substantive enactment.

Accounting for Uncertainty in Income Taxes

The Company applies the provisions of ASC Topic 740-10-25, Income Taxes – Overall – Recognition (“ASC Topic 740-10-25”) with respect to the accounting for uncertainty of income tax positions. ASC Topic 740-10-25 clarifies the accounting for uncertainty in income taxes recognized in a company’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740-10-25 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As of ~~September~~March 3031, 2022, tax years since ~~2014~~2018 remain ~~open~~ open for IRS audit. The Company has received no notice of audit from the Internal Revenue Service for any of the open tax years.

Revenue Recognition and Investment Income

Origination fees collected at the time of investment are recorded against the loans receivable and amortized into net interest income over the lives of the related loans. Issuance costs incurred are capitalized along with the initial investment and amortized against net interest income over the lives of the related loans. The Company records interest income in accordance with ASC subtopic 835-30 "Imputation of Interest", using the effective interest method. The ~~following is a summary of the components of the~~ Company’s ~~net~~had ~~investment~~no income for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~ 2023 and ~~2021~~2022.

	2022		2021
Interest Income	$	—	$	50,139
Accretion of Loan Origination Fees		—		33,441
Amortization of Loan Issuance Costs		—		(62,001	)
Net Investment Income	$	—	$	21,579

When a loan is placed on non-accrual status, the related interest receivable is charged to bad debt of the current period. If a non-accrual loan is returned to accrual status, the accrued interest existing at the date the residential loan is placed on non-accrual status and interest during the non-accrual period are recorded as interest income as of the date the loan no longer meets the non-accrual criteria.

The Company suspends recognizing interest income when it is probable that the Company will be unable to collect all payments according to the contractual terms of the underlying agreements. Management considers all information available in assessing collectability. Collectability is measured on a receivable-by-receivable basis by either the present value of estimated future cash flows discounted at the effective rate, the observable market price for the receivable or the fair value of the collateral if the receivable is collateral dependent. Large groups of smaller balance homogeneous receivables, such as pre-settlement funding transactions, are collectively assessed for collectability. Receivables, including those arising from the sale of loan origination services, is charged off when in the Company's judgment, the receivable or portion of the receivable is considered uncollectible.

Payments received on past due receivables and ~~finance~~ finance receivables the Company has suspended recognizing interest income on are applied first to principal and then to accrued interest. ~~Interest~~ Interest income on past due receivables and finance receivables, if received, is recorded using the cash basis method of accounting. Additionally, the Company generally does not resume recognition of interest income once it has been suspended. At December 31, 2021, the Company evaluated the collectability of its loans and lines of credit receivable, in light of economic conditions during the Covid-19 pandemic, established an allowance account to bring these to $0. Accordingly, there is no imputed interest receivable for the ~~nine~~three months ended ~~September~~March 3031, 2023 or 2022.

Variable Interest Entity

Paris Med

Omega Commercial Finance Corp.

Variable Interest Entity

The Company holds a 10% interest in Paris Med, of of which the remaining 90% interest is held by Omega. Through ~~December~~March 31, ~~2021~~2022, the Company has provided 100% of the funding to ~~Paris~~ Paris Med, which has provided a construction loan to a third party. This loan receivable is the sole asset of Paris Med. The ~~Company~~ Company determined that Paris Med was a variable interest entity based on various qualitative and quantitative factors including but not ~~limited~~ limited to: 1) financing of Paris Med’s sole asset was received by the Company, which is disproportionate to the Company’s ~~ownership~~ ownership interest and 2) the Company and Omega, a related party, organized the entity for the purpose of facilitating the Company’s activities. As of ~~September~~March 3031, ~~2022~~2023, the Company is considered the primary beneficiary because it has provided substantially all of its financial support and is the only party at risk. As of ~~December~~March 31, ~~2021~~2023, Paris Med has total assets of $0 because the Company established a full reserve ~~against~~for this ~~VIE~~loan until such time as the loan is repaid. See Note 4. For the ~~nine~~three months ended ~~September 30~~March 31, ~~2022~~2023, Paris Med had no activity. ~~At December 31 2021 and September 30, 2022, the Company established a full reserve against this VIE until such time as the loan is repaid.~~

Fair Value

The carrying amounts reported in the balance sheet for cash, accounts payable and notes payable approximate their estimated fair market value based on the short-term maturity of this instrument. The carrying value of the Company’s loans receivable approximate fair value because their terms approximate market rates.

Net Loss Per Share

Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding for the year. Dilutive loss per share reflects the potential dilution of securities that could share in the losses of the Company. 36,667 shares underlying convertible preferred stock ~~and 170,000 shares of common stock underlying common stock warrants~~ were excluded from the computation of diluted loss per share for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, because their impact was anti-dilutive.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and loans receivable. The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. Management has established an allowance of $1,633,380 as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022.

Recently Issued and Adopted Accounting Pronouncements

Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments. The amendments introduce an impairment model that is based on expected credit losses (“ECL”), rather than incurred losses, to estimate credit losses on certain types of financial instruments (ex. loans and held to maturity securities), including certain off-balance sheet financial instruments (ex. commitments to extend credit and standby letters of credit that are not unconditionally cancellable). The ECL should consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. Financial instruments with similar risk characteristics may be grouped together when estimating the ECL. The ASU also amends the current available for sale security impairment model for debt securities whereby credit losses relating to available for sale debt securities should be recorded through an allowance for credit losses. For an emerging growth company, the amendments in the update are effective for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021. The amendments will be applied through a modified retrospective approach, resulting in a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The Company is currently planning for the implementation of this accounting standard. It is too early to assess the impact this guidance, which is not effective for interim periods in 2021, will have on the Company’s financial statements.

The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

NOTE 4 – LOANS RECEIVABLE, NET

Loans Receivable - Related Parties

Loan Agreement with Partners South Holdings LLC (Revolving Line of Credit)

On August 28, 2017 the Company entered into a loan agreement with Partners South Holdings LLC (“Borrower”), which is owned by Timothy R. Fussell, President, Chairman of the Board and a director of the Company, for a revolving line of credit in the maximum principal sum of $3,600,000 for the purpose of financing real property construction costs and working capital needs. On January 28, 2020, this loan was amended to reduce the loan amount to $657,500. The maturity date of the loan is August 31, 2022 at which time the entire principal balance of the Loan plus accrued interest thereon is due and payable. The fixed interest rate on the loan is 3.5% and all interest receivables are due at maturity. As of December 31, 2021, $477,500 had been advanced on the loan, origination fees of $180,000 due to the Company have been added to the balance due on the loan and recorded as a discount against the loan to be amortized into income through the maturity date, and the Company also incurred loan issuance costs of $420,000, which were recorded as deferred issuance costs to be amortized as a reduction of interest income through the maturity date. During the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, the Company recognized $0 and $6220,~~001~~667, of the deferred issuance costs, which are carried at $0 and $0 as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022. As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, the Company has established a full reserve against this loan until such time as the loan is repaid~~; the gross loan receivable balance is $0~~.

Loan Agreement with Partners South Properties Corporation (Revolving Line of Credit)

On August 28, 2017, the Company entered into a loan agreement with Partners South Properties Corporation (“Borrower”), which is owned by Timothy R. Fussell, President, Chairman of the Board and a director of the Company, for a revolving line of credit in the maximum principal sum of $5,000,000 for the purpose of financing real property construction costs and working capital needs. On November 2, 2019, this loan was amended to reduce the loan amount to $250,000. The loan is secured in full by a first position lien on any and all Real Property in which the Borrower has any interest in for such purposes. The maturity date of the loan is August 31, 2022 at which time the entire principal balance of the loan plus accrued interest thereon is due and payable. The annual fixed interest rate on the loan is 3.5% and all interest receivables are due at maturity. As of ~~December~~March 31, ~~2021,~~2023 ~~the~~and ~~Company~~December ~~has~~31, ~~established~~2022, areceivable ~~full~~balance ~~reserve~~is ~~against the~~ $250,000 ~~receivable~~and ~~balance~~is fully reserved against until such time as the loan is is repaid. ~~As of September 30, 2022 and December 31, 2021, the receivable balance is $0.~~

Loans Receivable

Paris Med

On May 2, 2018, the Company and Paris Med entered into agreements, pursuant to which Paris Med agreed to provide project financing in the amount of $158,216,541, to an unrelated third party consisting of three notes as follows:

1) Construction financing in the amount of $90,204,328, maturing in 10 years, including the construction period, and accruing interest at an annual rate of 5.5% during the construction period, and 4.5% upon conversion to a permanent loan. As of December 31, ~~2020~~2019, Paris Med has made $558,000 of advances pursuant to the construction loan. The Company received loan origination fees, in the amount of $92,400, which is presented net of the underlying loan advances on the accompanying consolidated balance sheets and amortized into income over the terms of the underlying loans. During the three months ended March 31, 2023 and 2022, the Company amortized $0 and $2,290, respectively, of the discount. As of March 31, 2023 and December 31, 2022, the receivable balance is $0. The Company has established a full reserve against this loan until such as the loan may be repaid.

2) Equipment financing note in the amount of $24,715,986, payable monthly, accruing interest at an annual rate of 5.75%, and having terms approximating the lives of the underlying equipment. As of ~~September~~March 3031, 2023 and December 31, 2022, no amounts have been advanced pursuant to the equipment financing note.

3) Operations financing, business line of credit in the amount of $23,932,625, accruing interest at an annual rate of 5.75%, maturing in 10 years. As of ~~September~~March 3031, 2023 and December 31, 2022, no amounts have been advanced pursuant to the line of credit.

The notes are secured by the assignment of leases and fixed assets related to the project.

InThe ~~December 2021, the~~ Company established a full reserve against this loan until such time as the loan is repaid. ~~As of September 30, 2022 and December 31, 2021, the receivable balance is $0.~~

NOTE 5 - COMMITMENTS AND CONTINGENCIES

Alpha Mortgage Notes, LLC

In exchange for its 90% interest in the Alpha Mortgage Notes, LLC, ("SPV") the Company is required to contribute 4,015,667 shares of common stock to be used by the SPV for the purchase of performing notes for the SPV. The SPV is required to make monthly distributions to its 10% member of $10,000 up until the time a purchase of the performing notes are made, and upon the acquisition of the six mortgages specified in the SPV's operating agreement, monthly payments of $150,000 per month from gross interest income received for 30 months; and 20% of any other future note purchases. The 10% partner will also receive an amount equal to 1% of the principal amounts received on each loan. For the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023, the Company accrued $9030,000 of distributions. As of ~~September~~March 3031, ~~2022~~2023, $~~430~~460,000 of minimum distributions are owed to the 10% partner.

Litigation

~~Judgements~~We ~~Payable~~are currently involved in the following legal proceedings:

Steven T. Matthiesen and Joanna K. Matthiesen, jointly and severally v. Tmothy Fussell et al. In the United States District Court, Southern District of Florida, Case No. 21CV62334. This breach of contract matter resulted in a default judgment against the Defendants in 2022 of $1,514,000 plus fees and costs. This case remains pending as to Defendants Timothy Fussell and Partners South Holdings, LLC only.

Fusion Lodgings LLC v. PLC et al, In the District Court, 160th Judicial District, Dallas County, TX, Cause No. DC-20-09139. This breach of contract matter resulted in a default judgment against the Defendants of $1,000,000 plus fees and costs.

Pending Litigation

Judicial Ruling

~~The~~Fusion ~~Company~~Lodgings isLLC ~~not~~v. ~~aware~~PLC et al, In the District Court, 160th Judicial District, Dallas County, TX, Cause No. DC-20-09139. This breach of ~~any~~contract matter ~~additional~~resulted ~~litigation~~in a default judgment against the Defendants of $1,000,000 plus fees and costs.

Supplemental complaint for financial relief in regards to collections, In the circuit court of the eleventh judicial circuit in and for Miami-Dade County, Florida, case #2021-20869-CA01, seeking $144,147 plus 6% interest from 2013. The Company is currently in negotiations with plaintiff.

Advisory Agreement

In June 2019, the Company entered into an advisory agreement, pursuant to which it agreed to compensate a third-party advisor a percentage of future capital raises facilitated by the advisor. Compensation includes non-refundable cash, cash compensation based on a percentage of capital raised. The advisor may elect to receive certain percentage-based fees in the form of equity. Upon the closing of a transaction, the advisor will receive five-year warrants to purchase a number of shares of common stock equal to 8% of the number of shares issue in the transaction at a strike price of the transaction value as defined the agreement. As of the date of this report, no amounts have been earned and no equity instruments have been issued as transaction-based fees pursuant to this agreement.

NOTE 6 – ~~NOTE~~RELATED ~~PAYABLE~~PARTY ~~SHORT-TERM~~TRANSACTIONS

On June 29, 2022, the Company received a $35,000 6-month loan from an unrelated party bearing 24% annual interest, principal and interest due on December 29, 2022, extendable for 3 months with payment of three months accrued interest or $2,100 with no prepayment penalty. The money is earmarked for support functions, legal, accounting, and filing expenses related to compliance filings and completion of the S-1. As of September 30, 2022, the Company has accrued $2,100 in interest to be paid and expensed $2,100 for interest expense.

NOTE 7 – RELATED PARTY TRANSACTIONS

Loans receivable

The Company has extended lines of credit and loans to related parties. See Note 4.

Management Fee

The Company pays its parent company, Omega Commercial Finance Corp (“Omega”) management fees pursuant to a corporate governance management agreement executed on June 1, 2017. Omega is to provide services related to facilitating the introduction of potential investors for compensation not to exceed $300,000 per year. The agreement remains in effect until cancelled by Omega. During the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, the company accrued ~~management~~ management fees of $~~112~~37,500. Total management fees of $~~412~~487,500 and $~~300~~450,000 remain unpaid as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022.

Note Payable

On October 14, 2020, the Company issue a promissory note in the amount of $175,000 to Partners South, Holdings, LLC. The note bears interest at an annual rate of 10% and matured on December 15, 2020. The note is in default and due on demand. As of March 31, 2023 and December 31, 2022, the Company recorded $238,309 and $231,747 in Notes payable - related party

Note Payable – short term

Note Payable - Unrelated Party

On June 29, 2022, the Company issued a promissory note in the amount of $35,000 to an unrelated party. The note bears interest at an annual rate of 24% and matured on December 29, 2022. This note is currently in default, incurring interest at the default rate of 3.5% monthly on the unpaid balance. As of March 31, 2023 and December 31, 2022, the Company recorded $42,954 and $39,279 in Notes payable – short term. As of March 31, 2023 and 2022, the Company recorded $3,625 and $0 in interest expense.

~~Note~~NOTE ~~Payable~~7 – ~~related~~STOCKHOLDERS’ ~~party~~EQUITY

On October 14, 2020, the Company issue a promissory note in the amount of $175,000 to Partners South, Holdings, LLC. The note bears interest at an annual rate of 10% and matured on December 15, 2020. The note is in default and due on demand. As of September 30, 2022 and December 31, 2021, the Company recorded $225,185 and $205,497 in Notes payable - related party

NOTE 8 – STOCKHOLDERS’ EQUITY

Temporary Equity

On November 27, 2017, 16,667 shares of Series 2018 Convertible Preferred stock were issued at a value of $15.00 per share to one entity in exchange for cash of $250,000. The shares ~~had~~have 350,000 warrants attached, each warrant entitling the holder to one additional share with an exercise date of up to 5 years from ~~the~~ the issuance date of the shares~~; these warrants have expired~~. The preferred stock is mandatorily redeemable 10 years after issuance. On January 15, 2018, the Company issued 20,000 shares of Series 2018 to Partners South Holding LLC for services provided at $15 per share, no warrants attached. The Company allocated $236,897 the proceeds from the sale of the preferred stock to the warrants, which was recorded as a discount against the preferred stock and is to be amortized as a deemed dividend through the 10-year redemption date. The balance of the preferred stock reflected in temporary equity as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, was $~~428~~440,~~176~~020 and $~~410~~434,~~410~~098, net of unamortized discounts of $~~122~~110,~~403~~559 and $~~140~~116,~~169~~481, respectively.

~~Preferred~~ Common Stock

~~Series~~In Aorder ~~Convertible~~to ~~Preferred~~provide ~~Stock.~~the Company with an improved capital structure effective June 30, 2021, the Company implemented a capital restructuring pursuant to which:

~~In November 2017~~Omega, ~~the~~ ~~Company’s~~our ~~board~~principal ofstockholder ~~directors~~exchanged ~~designated 100~~28,~~000 authorized shares of Series A Convertible Preferred Stock (“Series A”). Each share of Series A has a par value of $15.00 and has no voting or dividend rights. Upon liquidation~~600, ~~dissolution or wining up, the~~999 ~~holders of Series A~~ shares ~~are entitled to be paid out~~ of ~~the~~our ~~assets of the Company, if any, ratably with the~~ common stock ~~holders.~~it ~~Each share~~held offor ~~Series~~100,000 ~~A is convertible within one year of issuance into two~~ shares of ~~common~~newly ~~stock~~designated ofSeries ~~the~~AA ~~Company.~~Preferred AtStock; ~~any~~and· ~~time~~Holders ~~after~~of ~~180~~an ~~days~~additional ~~of issuance~~1, ~~the Company has the right~~965,000 ~~but~~shares ~~not the obligation, to redeem all, but not less than all,~~ of ~~the~~our ~~outstanding Series A shares by paying cash,~~ common stock, orcontributed asuch ~~combination of both an amount equal to the par value of the Series A~~ shares. ~~On the one-year anniversary of issuance, the Company has an option~~ to ~~redeem~~ the ~~Series~~capital ~~A shares for an amount equal to the par value~~ of the ~~Series A shares~~Company. ~~There are 1,167 shares of Series A Convertible Preferred Stock outstanding as of September 30, 2022 and December 31, 2021.~~

Each share of Series AA ~~Convertible~~Preferred Stock is convertible at the option of the holder into ten (10) shares of the Company’s common stock for an aggregate of 1,000,000 shares of common stock, subject to adjustment for stock splits, stock dividends and similar transactions. The Series AA Preferred ~~Issuance~~Stock is entitled to share ratably in dividends declared on the Company’s common stock on an “as converted” basis.

InEach ~~February,~~share ~~2021,~~of ~~Alpha issued 100,000~~ Series AA ~~Convertible~~ Preferred ~~Shares~~Stock is entitled to ~~Omega~~450 ~~Commercial~~votes ~~Finance~~on ~~Corporation~~each ~~which represents~~matter ~~100%~~presented ofto ~~the~~stockholders ~~issued~~(subject ~~and~~to ~~outstanding~~adjustment ~~Series~~for ~~AA Convertible~~stock ~~Preferred~~splits, ~~Shares.~~stock ~~Each~~dividends ~~share~~and similar transactions). Shares of Series AA Preferred Stock ~~shall~~vote ~~entitle the~~together ~~holder~~with ~~thereof~~shares toof ~~four~~our ~~hundred~~common ~~fifty~~stock ~~(450) votes~~as ona ~~all~~single ~~matters~~class, ~~submitted~~except toas arequired ~~vote~~by ofDelaware ~~the~~law. Accordingly, ~~stockholders~~Omega, ofas the ~~Company.~~holder ~~Each~~of ~~share~~the of Series AA Preferred Stock ~~shall be convertible~~, at ~~the~~effectively ~~option~~maintains ofcontrol over the ~~holder~~Company’s ~~thereof,~~affairs atfollowing implementation ~~any~~of ~~time~~the ~~and~~capital ~~from~~restructuring ~~time to time, into ten (10) fully paid~~ and ~~non-assessable~~the ~~shares~~consummation of ~~Common Stock~~this ~~(the “Conversion Amount”)~~Offering. ~~There~~Alpha’s ~~are~~current ~~100,000~~issued ~~shares~~and ~~of Series AA Convertible Preferred Stock~~ outstanding ~~as of September~~common ~~30,~~stock ~~2022~~is ~~and December 31~~9, ~~2021~~724,401.

Capital Contributions

During the ~~nine~~three months ended ~~September~~March 3031, 2023 and 2022, Omega Commercial Finance Corp made a cash ~~contribution~~contributions to the Company of $738,~~630.~~250 ~~This was classified as capital contribution~~ and ~~recorded in additional paid-in capital~~$32,600.

Common Stock Warrants

AsThere ~~of September 30, 2022, there~~ are ~~warrants~~no outstanding towarrants as ~~purchase 170,000 shares for an exercise price~~ of ~~$15.00~~March ~~over five years~~31, ~~which~~2023 ~~expire~~and on December 14 31, 2022.

The following is a summary of warrants outstanding as of September 30, 2022:

Stockholders’ Equity - Schedule of Warrants Outstanding

Exercise Price				# of Shares				Expiration
$	15.00				170,000				December 14, 2022

NOTE 9 – SUBSEQUENT EVENTS

~~Common~~ Stock ~~Warrants~~ purchase

AsSubsequent ~~of December 14, 2022, the remaining outstanding warrants expired. As of December 14, 2022, there are no outstanding warrants.~~Event

On May 10, 2023, Omega Worldwide LLC purchased 1,500,000 restricted shares of common stock for $1,500 or $0.001/share.

The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no such events that warrant disclosure or recognition in the consolidated financial statements presented herein.

1615

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Management’s Discussion and Analysis of Financial Condition and Results of Operations is intended to provide a reader of our financial statements with a narrative from the perspective of our management on our financial condition, results of operations, liquidity, and certain other factors that may affect our future results. The following discussion and analysis should be read in conjunction with our audited consolidated financial statements and the accompanying notes thereto included in “Item 8. Financial Statements and Supplementary Data.” In addition to historical financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. See “Forward-Looking Statements.” Our results and the timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors.

Results of Operations

General

We have recognized no income from related parties for the three months ended ~~September~~March 3031, ~~2022~~2023, compared to ~~$7,193~~no revenue for the same period in ~~2021, resulting from the amortization of loan origination fees received in the form of cash and notes receivable, offset by the amortization of loan costs incurred~~2022. As of ~~September~~ 30March 31, ~~2022~~2023, the Company had an accumulated deficit of approximately $710.47 million.

The following table provides selected consolidated balance sheet data as of ~~September~~March 3031, ~~2022~~2023.

Balance Sheet Data:	~~9/30/2022~~	3/31/2022
Cash	$	~~127~~$	0
Loan receivable and accrued interest receivable, net of discounts		0	0
Total assets		~~2062006~~	0
Current liabilities		~~4,129,476~~	4,572,776
Total liabilities		~~4,129,476~~	4,572,776
Temporary equity		~~428,176~~	440,020
Shareholders' equity		~~(4,557,446)~~	(5,012,796	)

Three Months Ended ~~September 30~~March 31, ~~2022~~2023 as compared to ~~Three~~three ~~Months~~months ~~Ended~~ended ~~September~~March 3031, ~~2021~~2022

For the three months ended ~~September~~ 30March 31, ~~2022~~2023, we generated $0 noin ~~net investment~~ income, compared to $~~7,193~~0 in ~~2021~~2022. ~~Net investment income in 2021 resulted from interest income of $16,000, the amortization of loan origination fees of $110,000, offset by the amortization of loan costs of $21,000.~~ We incurred $~~116~~95,~~716~~200 in operating expenses during the ~~2022~~2023 period, compared to $92119,~~882~~799 in ~~2021~~2022.

Nine Months Ended September 30, 2022 as compared to Nine Months Ended September 30, 2021

For the nine months ended September 30, 2022, we generated no net investment income, compared to $21,579 in 2021. Net investment income in 2021 resulted from interest income of $48,000, the amortization of loan origination fees of $330,000, offset by the amortization of loan costs of $78,000. We incurred $417,814 in operating expenses during the 2022 period, compared to $288,917 in 2021.

Liquidity and Capital Resources

During the ~~nine~~three months ended ~~September~~ 30March 31, ~~2022~~2023, Omega, the principal stockholder of the Company, made an additional capital ~~contributions~~contribution to the Company of $738,~~650, compared to $191,211 in 2021~~250. InDuring ~~addition, on June 29, 2022,~~ the ~~Company~~three ~~received~~months ~~a short-term loan of $35,000 from an unrelated party,~~ended ~~bearing~~March ~~interest of $24%~~31, ~~interest and principal of $39~~2021,~~200~~ ~~due~~Omega ~~and~~made ~~payable~~cash oncontributions ~~December 29, 2022, extendable for three months with payment~~ of $232,~~100 in accrued interest~~600.

Critical Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods presented. The Company is required to make judgments and estimates about the effect of matters that are inherently uncertain. The Company regularly evaluates estimates and assumptions related to the valuation of the allowance for loan losses, loss contingencies, useful life and recoverability of long-lived assets, deferred income tax asset valuations and loss contingencies. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Although, we believe our judgments and estimates are appropriate, actual future results may be different; if different assumptions or conditions were to prevail, the results could be materially different from our reported results.

expenses that are not readily apparent from other sources. Although, we believe our judgments and estimates are appropriate, actual future results may be different; if different assumptions or conditions were to prevail, the results could be materially different from our reported results.

Loans Receivable, net and Allowance for Losses

The Company records its investments in loans receivable at cost less unamortized costs of issuance and deferred origination fees. Origination fees collected at the time of investment are recorded against the loans receivable and amortized into net interest income over the lives of the related loans. Issuance costs incurred are capitalized along with the initial investment and amortized against net interest income over the lives of the related loans.

When a loan receivable is placed on non-accrual status, the related interest receivable is reversed against interest income of the current period. If a non-accrual loan is returned to accrual status, the accrued interest existing at the date the residential loan is placed on non-accrual status and interest during the non-accrual period are recorded as interest income as of the date the loan no longer meets the non-accrual criteria.

The Company maintains an allowance for loan losses on its investments in real estate loans receivable for estimated credit impairment. Management’s estimate of losses is based on a number of factors including the types and dollar amounts of loans in the portfolio, adverse situations that may affect the borrower’s ability to repay, prevailing economic conditions and the underlying collateral securing the loan. Additions to the allowance are provided through a charge to earnings and are based on an assessment of certain factors, which may indicate estimated losses on the loans. Actual losses on loans are recorded first as a reduction to the allowance for loan losses. Generally, subsequent recoveries of amounts previously charged off are recognized as income.

Off-Balance Sheet Arrangements

There are no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

As a smaller reporting company, we are not required to include disclosure under this item.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

As of ~~September~~March 3031, ~~2022~~2023, our Chief Executive Officer (our principal executive and financial officer) conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures; as is defined in Rule 13a-15(e) of Exchange Act. We recognize that there are material weaknesses related to our internal controls. Therefore, our Chief Executive Officer has concluded that our disclosure controls and procedures were not effective, as of the end of the period covered by this Annual Report on Form 10-K. This includes ensuring that information required to be disclosed was recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Furthermore, to provide reasonable assurance that information required to be disclosed is accumulated and communicated as appropriate to allow timely decisions regarding required disclosure.

Management’s Report on Internal Control over Financial Reporting

Our Chief Executive Officer (our principal executive and financial officer) is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. We have designed our internal controls to provide reasonable assurance that our financial statements are prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP), and include those policies and procedures that:

pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and disposition of our assets;

provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with authorization of our management and directors; and

provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Our Chief Executive Officer (our principal executive and financial officer) conducted an evaluation of the effectiveness of our internal controls over financial reporting as of ~~September 30,~~March 31, 2022. In making this evaluation, the Chief Executive Officer used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in its 2013 Internal Control — Integrated Framework.

Based on this evaluation, our Chief Executive Officer has concluded that our internal controls over financial reporting were not effective as of the end of the period covered in this Quarterly Report on Form 10-K. The Chief Executive Officer has concluded that the financial statements included in this report fairly present in all material respects our financial position and results of operations.

This Quarterly Report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. The Chief Executive Officer’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the SEC that permit the Company to provide only management’s report in this annual report.

Changes in Internal Control over Financial Reporting

During the quarter ended ~~September~~March 3031, ~~2022~~2023, there ~~have~~ have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II

ITEM 1. LEGAL PROCEEDINGS

~~Steven~~We T.are ~~Matthiesen~~currently ~~and Joanna K. Matthiesen, jointly~~involved ~~and severally v. Tmothy Fussell et al. In the United States District Court, Southern District of Florida, Case No. 21CV62334. This breach of contract matter resulted~~ in ~~a default judgment against~~ the ~~Defendants~~following inlegal ~~2022 of $1,514,000 plus fees and costs. This case remains pending as to Defendants Timothy Fussell and PartnersSouth Holdings, LLC only.~~proceedings:

WeSteven ~~are~~T. ~~currently~~Matthiesen ~~not~~and Joanna aK. ~~party~~Matthiesen, tojointly ~~any~~and ~~material~~severally ~~legal or~~v. ~~administrative~~Tmothy ~~proceedings~~Fussell ~~and~~et ~~are~~al. ~~not~~In ~~aware~~the ofUnited ~~any~~States ~~pending~~District orCourt, ~~threatened~~Southern ~~material~~District ~~legal~~of orFlorida, Case ~~administrative~~No. ~~proceedings~~21CV62334. ~~arising~~This breach of contract matter resulted in ~~the ordinary~~a ~~course~~default ofjudgment ~~business. We~~against ~~may~~the ~~from~~Defendants ~~time~~in to2022 ~~time~~of ~~become~~$1,514,000 aplus ~~party~~fees and tocosts. ~~various~~This ~~legal~~case orremains ~~administrative~~pending ~~proceedings~~as ~~arising in~~to ~~the~~Defendants ~~ordinary~~Timothy ~~course~~Fussell ofand ~~our~~Partners ~~business~~South Holdings, LLC only.

Fusion Lodgings LLC v. PLC et al, In the District Court, 160^th Judicial District, Dallas County, TX, Cause No. DC-20-09139. This breach of contract matter resulted in a default judgment against the Defendants of $1,000,000 plus fees and costs.

We are not aware of any other pending or threatened material legal or administrative proceedings arising in the ordinary course of business. We may from time to time become a party to various legal or administrative proceedings arising in the ordinary course of our business.

ITEM 1A. RISK FACTORS

Risk factors describing the major risks to our business can be found under Item 1A, “Risk Factors”, in our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022. There has been no material change in our risk factors from those previously discussed in the Annual Report on Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

~~None~~On May 10, 2023, Omega Worldwide LLC purchased 1,500,000 restricted shares of common stock for $1,500 or $.001/share, the proceeds from which were used for operating expenses of the corporation.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable to our operations.

ITEM 5. OTHER INFORMATION

See ITEM 1A above.

ITEM 6. EXHIBITS

Exhibit Number		Description

31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act*
31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act*
32.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

101.INS	XBRL Instance Document *
101.SCH	XBRL Taxonomy Extension Schema Document *
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document *
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document *
101.LAB	XBRL Taxonomy Extension Label Linkbase Document *
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document *

* Filed herein

2019

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ALPHA INVESTMENT INC.

/s/ Todd C. Buxton		Chief Executive Officer, Acting Chief Financial Officer and Director		~~December~~August 197, ~~2022~~2023
TODD C. BUXTON		Title (Principal Executive, financial and Accounting Officer		Date

2120

Filing Compare · Alpha Investment Inc.